Faes Farma S.A./€FAE
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Faes Farma S.A.
Faes Farma S.A. is a pharmaceutical company engaged in the research, production, and marketing of pharmaceutical products. Headquartered in Leioa, Spain, the company operates primarily in the pharmaceuticals and animal health sectors. Key products include prescription medications for human health, over-the-counter medicines, and nutritional supplements, as well as products for veterinary use. Founded in 1933, Faes Farma has expanded its operations to various international markets, particularly in Europe and Latin America. Its competitive strength lies in its robust R&D capabilities and a well-established distribution network.
Ticker
€FAE
Sector
Primary listing
BME
Industry
Pharmaceuticals
Headquarters
Employees
1,894
Website
Faes Farma S.A. Metrics
BasicAdvanced
€1.4B
12.91
€0.34
0.32
€0.14
3.33%
Price and volume
Market cap
€1.4B
Beta
0.32
52-week high
€4.73
52-week low
€3.27
Average daily volume
144K
Dividend rate
€0.14
Financial strength
Current ratio
2.294
Quick ratio
1.454
Long term debt to equity
0.676
Total debt to equity
11.475
Dividend payout ratio (TTM)
46.39%
Interest coverage (TTM)
234.80%
Profitability
EBITDA (TTM)
117.125
Gross margin (TTM)
64.71%
Net profit margin (TTM)
19.37%
Operating margin (TTM)
18.70%
Effective tax rate (TTM)
-4.71%
Revenue per employee (TTM)
€290,000
Management effectiveness
Return on assets (TTM)
6.92%
Return on equity (TTM)
14.83%
Valuation
Price to earnings (TTM)
12.908
Price to revenue (TTM)
2.49
Price to book
1.86
Price to tangible book (TTM)
2.66
Price to free cash flow (TTM)
18.662
Free cash flow yield (TTM)
5.36%
Free cash flow per share (TTM)
0.233
Dividend yield (TTM)
3.33%
Growth
Revenue change (TTM)
10.13%
Earnings per share change (TTM)
7.99%
3-year revenue growth (CAGR)
5.31%
10-year revenue growth (CAGR)
10.36%
3-year earnings per share growth (CAGR)
5.91%
10-year earnings per share growth (CAGR)
11.57%
Bulls say / Bears say
Faes Farma's acquisition of Laboratorios Edol for €75 million is expected to double its sales and EBITDA in Portugal, enhancing its international market presence and creating synergies with its R&D efforts. (tipranks.com)
The company's strategic plan for 2025-2030 aims for revenue growth of 11-12% CAGR, targeting €1 billion in revenues by 2030, driven by strong international sales performance, particularly in LATAM and Gulf regions. (reuters.com)
Analysts have increased Faes Farma's price target by 14.60% to €4.60, reflecting confidence in the company's growth prospects and strategic initiatives. (fintel.io)
Despite revenue growth, Faes Farma's Q1 2025 results showed margin pressure due to increased expenses aligned with its strategic plan, potentially impacting short-term profitability. (investing.com)
The company's revenue is forecasted to decline by an average of 2.6% per year over the next three years, indicating potential challenges in sustaining growth. (simplywall.st)
Faes Farma's dividend yield of 4.18% is not well covered by free cash flows, raising concerns about the sustainability of its dividend payouts. (simplywall.st)
Data summarised monthly by Lightyear AI. Last updated on 3 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Faes Farma S.A. stock?
Faes Farma S.A. (FAE) has a market cap of €1.4B as of August 01, 2025.
What is the P/E ratio for Faes Farma S.A. stock?
The price to earnings (P/E) ratio for Faes Farma S.A. (FAE) stock is 12.91 as of August 01, 2025.
Does Faes Farma S.A. stock pay dividends?
Yes, the Faes Farma S.A. (FAE) stock pays dividends to shareholders. As of August 01, 2025, the dividend rate is €0.14499 and the yield is 3.33%. Faes Farma S.A. has a payout ratio of 46.39% on a trailing twelve-month basis.
When is the next Faes Farma S.A. dividend payment date?
The next Faes Farma S.A. (FAE) dividend payment date is unconfirmed.
What is the beta indicator for Faes Farma S.A.?
Faes Farma S.A. (FAE) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.